Arca
Skip to content
Tools
Tools

Fatty acids

Small molecule in Homo sapiens that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 2
  • In phases 1 to 3: 0
  • Sponsors: 2

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 2

Approved2

  • Pancrelipase
  • Lipase (pancrelipase)

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        PancrelipaseApprovedOrganonProtein or peptideHydrolytic enzymeFatty acids hydrolytic enzyme15
        Lipase (pancrelipase)ApprovedAimmune Nestlé Health Science US R&D, LLCProtein or peptideHydrolytic enzymeFatty acids hydrolytic enzyme7

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 12 in all, from ClinicalTrials.gov.
        Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 DiabetesPancrelipasePhase 4RecruitingSilesian Centre for Heart DiseasesOct 1, 2026
        A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal SurgeryPancrelipaseNot applicableNot yet recruitingTianjin Medical University Cancer Institute and HospitalAug 7, 2026
        Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid HypofunctionPancrelipaseNot applicableRecruitingCairo UniversityMay 15, 2026
        A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.Pancrelipase, Lipase (pancrelipase)Phase 2RecruitingAimmune Nestlé Health Science US R&D, LLCApr 30, 2026
        A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui Tongbian Capsules Combined With Pancreatin Enteric-coated Capsules on Pancreatic Exocrine Function in Patients After Curative Resection for Pancreatic CancerPancrelipasePhase 4Not yet recruitingShanghai General Hospital, Shanghai Jiao Tong University School of MedicineApr 29, 2026
        Phase 2 Study to Assess the Safety and Efficacy of ANG003Pancrelipase, Lipase (pancrelipase)Phase 2RecruitingAnagram Therapeutics, Inc.Mar 4, 2026
        A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic PancreatitisPancrelipase, Lipase (pancrelipase)Early phase 1RecruitingShanghai Changzheng HospitalJan 2, 2026
        Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic PancreatitisPancrelipaseNot applicableRecruitingChanghai HospitalJul 20, 2025
        Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)Lipase (pancrelipase)Not applicableRecruitingPhilipp SchuetzFeb 13, 2025
        Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic InsufficiencyLipase (pancrelipase)Phase 4RecruitingOhio State UniversityJun 27, 2024
        Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)Lipase (pancrelipase)Phase 1 / Phase 2Active, not recruitingMemorial Sloan Kettering Cancer CenterDec 8, 2022
        Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic InsufficiencyLipase (pancrelipase)Phase 2Active, not recruitingAndrew Hendifar, MDSep 23, 2019

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364711, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.